Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease

In patients with clinical evident vascular disease, lower adiponectin levels were associated with a lower cardiovascular risk. Therefore, it may be hypothesized that the potential antiatherosclerotic properties of adiponectin do not apply for patients with already established vascular disease.